High-throughput screening assays for CYP2B6 metabolism and inhibition using fluorogenic vivid substrates

Area of Science:

• Biochemistry
• Pharmacology
• Toxicology

Background:

• Cytochrome P450 2B6 (CYP2B6) is a polymorphic enzyme crucial for metabolizing endogenous and exogenous compounds.
• CYP2B6 plays a role in procarcinogen activation, contributing to carcinogenesis.
• Limited availability of validated high-throughput screening (HTS) assays has hindered comprehensive studies of CYP2B6 in drug metabolism.

Purpose of the Study:

• To develop and validate novel fluorescence-based HTS assays for human CYP2B6.
• To characterize the utility of these assays for screening compound metabolism and inhibition.
• To provide a robust tool for advancing CYP2B6 research.

Main Methods:

• Development of two novel fluorogenic substrates: Vivid CYP2B6 Blue and Cyan Substrates.
• Utilized recombinant human CYP2B6 for assay development.
• Validated assays by testing known CYP2B6 substrates, inhibitors, and inducers to assess inhibitory potency.

Main Results:

• The developed Vivid CYP2B6 Blue and Cyan Assays demonstrated robustness, sensitivity, and broad dynamic ranges.
• Assay performance correlated well with previously published affinity measurements (Ki, Kd, or Km).
• Compound rankings for inhibitory potency in the new assays aligned with existing data.

Conclusions:

• The novel fluorescence-based HTS assays are effective tools for screening large compound libraries for CYP2B6 interactions.
• These assays facilitate a deeper understanding of CYP2B6's role in drug metabolism and potential carcinogenicity.
• The validated assays represent a significant advancement for CYP2B6 research.